Bluejay Diagnostics 

$1.96
25
+$0.07+3.7% Today

Statistics

Day High
1.88
Day Low
1.81
52W High
30
52W Low
1.77
Volume
4,243
Avg. Volume
228,427
Mkt Cap
3.56M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q2 2024
Q3 2024
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Next
-144
-96.24
-48.48
-0.72
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
0Revenue
-41.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BJDX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of diagnostics products, competing in the same market as Bluejay Diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific provides analytical instruments and reagents, directly competing in the diagnostics space.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the diagnostics sector, offering similar diagnostic solutions and competing for the same customer base.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers clinical diagnostics products, making it a direct competitor in the diagnostics field.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in diagnostics and medical imaging, positioning it as a competitor in the diagnostics market.
QuidelOrtho
QDEL
Mkt Cap1.83B
Quidel Corporation is known for its diagnostic healthcare products, competing in the same space as Bluejay Diagnostics.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America Holdings offers diagnostic services, making it a competitor by providing similar healthcare diagnostics solutions.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics Incorporated provides diagnostic testing services, competing directly with Bluejay Diagnostics' offerings.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation designs and manufactures scientific instruments, including diagnostics equipment, competing in the same market.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies, Inc. provides instruments, services, and consumables for laboratories, including diagnostics, making it a competitor.

About

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Show more...
CEO
Mr. Indranil Dey
Employees
7
Country
US
ISIN
US0956336087

Listings

0 Comments

Share your thoughts

FAQ

What is Bluejay Diagnostics stock price today?
The current price of BJDX is $1.96 USD — it has increased by +3.7% in the past 24 hours. Watch Bluejay Diagnostics stock price performance more closely on the chart.
What is Bluejay Diagnostics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bluejay Diagnostics stocks are traded under the ticker BJDX.
Is Bluejay Diagnostics stock price growing?
BJDX stock has fallen by -9.09% compared to the previous week, the month change is a -12.2% fall, over the last year Bluejay Diagnostics has showed a -87.84% decrease.
What is Bluejay Diagnostics market cap?
Today Bluejay Diagnostics has the market capitalization of 3.56M
When is the next Bluejay Diagnostics earnings date?
Bluejay Diagnostics is going to release the next earnings report on May 13, 2026.
What is Bluejay Diagnostics revenue for the last year?
Bluejay Diagnostics revenue for the last year amounts to 0 USD.
What is Bluejay Diagnostics net income for the last year?
BJDX net income for the last year is -41.88M USD.
How many employees does Bluejay Diagnostics have?
As of April 02, 2026, the company has 7 employees.
In which sector is Bluejay Diagnostics located?
Bluejay Diagnostics operates in the Health Care sector.
When did Bluejay Diagnostics complete a stock split?
The last stock split for Bluejay Diagnostics was on January 29, 2026 with a ratio of 1:4.
Where is Bluejay Diagnostics headquartered?
Bluejay Diagnostics is headquartered in Acton, US.